"Trousseau's disease:" a description of the Gilles de la Tourette syndrome 12 years before 1885.

French neurologist Georges Gilles de la Tourette first described the syndrome which earned him eponymous fame in 1885. However, a publication dated 1873 by Armand Trousseau included a detailed account of what is currently know as Gilles de la Tourette syndrome (GTS). In Gilles de la Tourette's celebrated 1885 paper, there is a brief mention of the clinical picture described earlier by Trousseau, but Gilles de la Tourette somewhat disregarded it.

Systemic amyloidosis with temporal artery involvement mimicking temporal arteritis.

A 77-year-old man presented with jaw claudication, arthralgias and myalgias, weight loss, marked fatigue, and thickened temporal arteries. No vasculitis was seen on the temporal artery biopsy specimen, but amyloidosis was suspected and confirmed with Congo red staining. Subsequent bone marrow biopsy revealed multiple myeloma.

Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production.

A female patient with acromegaly, hypercalcemia, and Zollinger-Ellison syndrome was found to have a very high plasma concentration (average 2,300 pmol/liter; normal less than 50 pmol/liter) of growth hormone-releasing factor as measured by a radioimmunoassay to human pituitary growth hormone-releasing factor-1-44. The plasma concentration of growth hormone averaged 25 mIU/liter (normal less than 5 mIU/liter) and there was no rise following an intravenous 100 micrograms bolus of human pituitary growth hormone-releasing factor-1-44. Plasma growth hormone and growth hormone-releasing factor levels were unaffected by bromocriptine, insulin-induced hypoglycemia, and sleep.